🇺🇸

US SEC Filing Intelligence

· daily

US SEC Filings Daily Market Digest — August 14, 2026

The August 14, 2026, filing batch reveals a market bifurcated between aggressive growth investments in AI, space, and critical minerals (e.g., Hancock Prospecting's $5.7B portfolio, Blue Sparrow's $10.3B tech-heavy fund) and a defensive, hedging posture among many institutional managers (e.g., Lonestar Capital's 53% put exposure, Yaupon Capital's $1.44B SPY put). Period-over-period data from operating companies shows a stark contrast: SaaS leader Intapp grew revenue 15% YoY but saw net losses widen 127%, while micro-cap SEATech and American Picture House remain cash-burning shells with no revenue. Insider activity is limited, but management changes at Lifeward (CFO departure) and Skye Bioscience (near-total dilution via reverse merger) signal significant governance shifts. Capital allocation trends are mixed, with Riverview Bancorp increasing buybacks while Edible Garden invests in growth. The most critical development is Skye Bioscience's acquisition of Redx Pharma, creating a new fibrosis leader with ~$125M in committed funding, though pre-deal shareholders face massive dilution. Portfolio-level patterns show a clear rotation toward SPACs and special situations (Shaolin Capital, Ghisallo Capital) and a defensive tilt with significant put buying on major indices, suggesting institutional caution on near-term market direction.

10 high priority 40 medium 50 total filings
· daily

S&P 500 Consumer Discretionary Sector SEC Filings — August 14, 2026

The five filings in this Consumer Discretionary stream reveal a mix of strategic M&A, insider selling, and opaque debt-related disclosures. Amazon's S-4/A for its Globalstar acquisition is the most material event, with a revised customer payment and satellite launch delay, though the deal remains on track with a neutral sentiment. O'Reilly Automotive's two insider sales (director and SVP) totaling ~$463K at prices around $92-93 signal potential management caution, especially given the lack of detail in its 8-K. Carvana's 8-K discloses a material definitive agreement creating a direct financial obligation, but with no specifics, raising uncertainty about its leverage. No period-over-period financial trends were available across filings, limiting cross-company comparisons. Key themes include insider selling in auto retail, strategic M&A in satellite communications, and a general lack of transparency in recent 8-Ks, which could impact investor confidence.

4 high priority 1 medium 5 total filings
· daily

S&P 500 Healthcare Sector SEC Filings — August 14, 2026

The two S&P 500 Healthcare filings for August 14, 2026, both involve significant insider stock sales by top executives at Becton Dickinson (BD) and Johnson & Johnson (JNJ), creating a bearish sentiment across the sector. The combined insider disposals total approximately $34.7 million, with JNJ's CEO alone selling $26.7 million worth of shares. While BD's CEO executed a pre-planned 10b5-1 sale, the sheer magnitude of JNJ's transaction—representing a 27% reduction in the CEO's holdings—raises concerns about management conviction. Period-over-period comparisons and forward-looking data were not provided in these filings, limiting trend analysis, but the insider activity pattern is the dominant signal. The lack of any positive capital allocation or guidance data in these filings amplifies the negative tone, suggesting investors should scrutinize upcoming earnings calls for context. Both companies remain core healthcare holdings, but the insider selling warrants a defensive posture until further clarity emerges on operational performance and strategic outlook.

2 high priority 2 total filings
· daily

US Earnings Financial Results SEC Filings — August 14, 2026

The 50 filings for the period ending August 14, 2026, reveal a bifurcated market landscape. While a handful of large-cap companies like Amcor (revenue +56.6% YoY) and Avnet (+24.5% YoY) demonstrate robust top-line growth driven by M&A and broad-based demand, the majority of filings, particularly from SPACs and pre-revenue biotechs, show continued cash burn and operational losses. A significant trend is the surge in SPAC IPOs, with 10 new blank-check companies raising over $1.5 billion in trust, though most report operating losses and widening accumulated deficits. The most critical development is the sharp deterioration in profitability for several real estate and credit funds, with Cottonwood Communities swinging from a $16.5M profit to a $9.7M loss and Apollo Infrastructure seeing net investment income turn negative. Insider activity is limited but notable, with Standex's CEO adopting a 10b5-1 plan to sell shares. Capital allocation trends are mixed, with some companies like Nektar Therapeutics aggressively raising equity ($890M) while others like Cyber Enviro-Tech face severe liquidity constraints. The overall portfolio-level pattern points to a 'growth at all costs' environment in emerging sectors, contrasted with margin discipline and shareholder returns in more mature industrials and packaging.

50 high priority 50 total filings
· daily

US Executive Compensation Proxy SEC Filings — August 14, 2026

The 10 DEF 14A filings reveal a governance-focused landscape with minimal operational data, yet key themes emerge: significant insider control at Sprott Focus Trust (CEO owns 54.8%), board refreshment at AeroVironment (two long-tenured directors retiring), and a shareholder-friendly fee reduction at Fidelity's Variable Insurance Products Fund V. Capital allocation is conservative across the board, with no dividends, buybacks, or M&A mentioned. Forward-looking catalysts cluster around annual meetings in September and October 2026, with AeroVironment's say-on-pay vote and America's Car-Mart's equity plan amendment being the most actionable. Period-over-period comparisons are sparse, but where present (e.g., AeroVironment's board size reduction), they signal governance evolution. Overall, the filings suggest a stable, low-volatility environment with limited immediate investment signals, but the insider concentration at Sprott and the fee reduction at Fidelity warrant attention.

10 high priority 10 total filings
· daily

US IPO Pipeline SEC S-1 Filings — August 14, 2026

The IPO pipeline digest reveals two distinct transactional events: Etoiles Capital Group's strategic re-domestication from the Cayman Islands to Nevada, aiming for structural and governance clarity while maintaining Nasdaq listing, and Colony Bankcorp's undisclosed business combination, offering a potential consolidation play in the banking sector. Both entities are using S-4 filings, typical for transformative corporate actions. Period-over-period data is absent for both, limiting trend-based analysis. The domestication of Etoiles is a material, vote-based catalyst shaping a new governance landscape, but lacks insider activity or financial metrics. Colony Bankcorp’s zero-materiality deal presents high reward-risk asymmetry. Key themes revolve around jurisdiction arbitrage and quiet banking consolidation. The critical implication: pipeline activity is shifting from capital raises to structural reorganizations, potentially signaling a pivot in IPO mechanics.

2 high priority 2 total filings
· daily

US SEC Trading Suspension Halt Orders — August 14, 2026

On August 14, 2026, a wave of delisting filings hit the SEC, with seven companies reporting failures to satisfy continued listing standards or receiving direct delisting notices. The cluster is concentrated in micro-cap and small-cap names across diverse sectors (battery tech, beverages, medical devices, telecom, advertising, clean energy, and biotech), suggesting a broad-based compliance crisis rather than a sector-specific shock. All filings carry bearish sentiment with high-to-critical risk levels, and none disclosed specific financial metrics, forward guidance, or insider activity, severely limiting quantitative trend analysis. The most severe events are Adagio Medical Holdings and Worksport Ltd, both rated critical risk with materiality scores of 10/10 and 9/10 respectively, indicating potential existential threats. The absence of period-over-period comparisons, insider transactions, and capital allocation data across all filings points to a common pattern of distressed companies filing minimal disclosures, likely to avoid further negative market reaction. The market implication is clear: investors face a liquidity and transparency vacuum, with forced selling and debt covenant triggers as immediate risks. This cluster represents the highest single-day delisting volume in recent memory, warranting heightened scrutiny of micro-cap exposure.

7 high priority 7 total filings
· daily

US Executive Officer Management Changes SEC — August 14, 2026

This digest of 38 regulatory filings reveals a day of significant leadership turnover across US equities, with a notable cluster of sudden CFO departures and a mass board resignation creating acute governance risks. The period-over-period data from the two earnings filings shows a mixed picture: Lifeward delivered strong 16% YoY revenue growth but suffered margin compression and a widened net loss, while Neumora Therapeutics narrowed its operating loss by 22% YoY but remains pre-revenue with a finite cash runway. A key pattern is the prevalence of internal promotions for CEO and CFO roles (Rhinebeck, Wheeler, Jacobs Solutions), suggesting a focus on continuity, contrasted sharply by the unexplained exits at Beauty Health Co and the complete board and officer walkout at Smart Powerr Corp. Insider trading activity was minimal, but the equity grant to Mastech Digital's CFO and the RSU awards to new directors at Aptera and Fermi provide compensation benchmarks. The overarching theme is a bifurcated market: stable, planned successions in established firms versus sudden, high-risk departures in smaller or distressed companies, demanding immediate investor scrutiny.

38 high priority 38 total filings
· daily

USA Insider Trading Pulse — August 14, 2026

Today's insider trading pulse reveals a bifurcated market with significant insider buying in energy and materials sectors, while technology and consumer discretionary names see notable insider selling. The most compelling signal is the massive $6.04M purchase by Borr Drilling's director, coupled with a $502K buy from another director, suggesting strong conviction in the offshore drilling recovery. Conversely, Winnebago's CEO and SVP both executed option exercises followed by stock sales under 10b5-1 plans, a bearish signal for the RV sector. Financial services show mixed signals, with PNC's EVP selling $858K while a director at Burke & Herbert bought $88K. The data reveals a pattern of insider accumulation in beaten-down cyclicals and small-cap value, while growth and tech names continue to see insider distribution. Notably, no forward-looking guidance changes were flagged in the enriched data, but the insider activity patterns suggest sector rotation into energy and materials.

50 high priority 50 total filings
· daily

US Merger & Acquisition SEC Filings — August 14, 2026

The August 14, 2026, US M&A filing stream is dominated by SPAC activity, with 7 of 13 filings involving special purpose acquisition companies, primarily focused on extending deadlines and managing cash runway. The most significant transaction is SpaceX's $60.0 billion all-stock acquisition of Anysphere (Cursor), a transformative deal that signals a major convergence of space technology and AI software. Proficient Auto Logistics' $75.0 million convertible note offering provides a capital allocation signal, using proceeds to refinance debt and manage dilution. A notable pattern is the lack of deal-specific financial details in several filings (Elme Communities, CENTERSPACE, Pinnacle Acquisition, OceanLight Acquisition), creating information asymmetry and risk. The aggregate data reveals a market where SPACs are buying time, while a single high-profile tech acquisition and a strategic debt refinancing offer the most actionable intelligence for investors.

13 high priority 13 total filings
· monthly

US Pre-Market SEC Filings Roundup — August 14, 2026

Overnight filings reveal a market with diverging signals: significant insider selling by major stakeholders in Silence Therapeutics and Sky Harbour Group contrasts with bullish insider buying in OppFi and Attovia Therapeutics, the latter seeing a director and Goldman Sachs collectively invest $17M. A notable pattern emerges with Balyasny Asset Management filing multiple passive 13G amendments, indicating a concentrated portfolio adjustment across several small-cap biotechs and SPACs. The most material operational update comes from Azul S.A., which reported record revenue but a sharp EBITDA decline and net loss due to surging fuel costs, highlighting severe margin compression in the airline sector. Meanwhile, the 21Shares Ethereum ETF reported a mixed quarter with staking rewards growth offset by significant unrealized losses from ether price declines. Institutional 13F filings from Desjardins, Firsthand Capital, and Oasis Management reveal varying strategies, with Oasis's large put options on QQQ signaling a bearish hedge on tech. Overall, the data points to cautious capital deployment, with insider selling for monetization and passive stake adjustments outweighing aggressive bullish bets.

23 high priority 27 medium 50 total filings
· daily

VA Healthcare & Services Contracts — August 13, 2026

This digest covers a single $84.6 million civilian contract from the Department of Veterans Affairs to QTC Medical Services Inc., a subsidiary of Leidos Holdings, Inc., for medical disability examinations in the Northeast region. The contract is fully funded, firm-fixed-price, and nearly fully outlayed ($80.9M spent), limiting forward revenue visibility despite its size. The award, made under full and open competition, signals Leidos’ established competitive position in VA health services but carries no defense exposure and offers minimal near-term growth catalyst. Key risk is the lack of follow-on contract visibility, as the one-year performance period (2020-2021) is effectively complete.

1 total filings
· daily

New Federal Contractors — August 13, 2026

This digest covers three contracts totaling $860.4 million, with a heavy civilian skew (two contracts from the Department of Education and Department of Veterans Affairs) and one defense-adjacent award from the General Services Administration. The dominant theme is stable, non-transformative revenue streams for large primes: Booz Allen Hamilton’s $136.2 million IT support contract at Tinker AFB and Leidos’ $84.6 million VA medical exam contract are competitive wins but represent modest fractions of each firm’s revenue. The highest-conviction signal is neutral—none of the contracts show bullish or bearish momentum—and the key risk is the $639.6 million Missouri Higher Education Loan Authority modification, which lacks sufficient detail to assess materiality or competitive dynamics, creating an information gap for investors.

3 total filings
· daily

Significant Contract Modifications ($10M+) — August 13, 2026

The August 13, 2026 contract modification stream totals $860.4 million across three awards, with a civilian-heavy split (2/3 civilian vs. 1/3 defense-adjacent). The dominant theme is federal services spending—IT support at Tinker AFB (Booz Allen Hamilton, $136.2M) and VA medical exams (QTC Medical Services/Leidos, $84.6M)—but the largest award by far is a $639.6M Department of Education modification to the Missouri Higher Education Loan Authority, which lacks detail and signals neutral investment impact. The highest-conviction signal is Booz Allen's competitive win under full-and-open competition, indicating sustained demand for defense-adjacent IT services, though its modest annual revenue (~$24.8M) limits materiality. Key risks include the nearly fully executed QTC/Leidos contract (no forward revenue) and the opaque Education modification, which warrants monitoring for budget or execution issues.

3 total filings
· daily

Contract Deobligations Alert — August 13, 2026

This digest covers three contracts totaling $860.4 million, with a heavily civilian tilt (2 of 3 contracts, $724.2 million) and only one defense-adjacent award ($136.2 million). The dominant agency theme is civilian health and education spending, led by a $639.6 million Department of Education modification to Missouri Higher Education Loan Authority—a neutral, low-visibility obligation. The highest-conviction signal is Booz Allen Hamilton’s $136.2 million competitive win at Tinker AFB, a stable defense-adjacent IT services contract with moderate pricing risk. A key risk is the near-complete execution of Leidos’ $84.6 million VA medical exam contract, leaving minimal forward revenue visibility for that subsidiary. No bullish or bearish signals were identified across the set; all three contracts are neutral, reflecting routine obligations rather than transformative wins or losses.

3 total filings
· daily

Contract Option Exercises — August 13, 2026

The three contracts analyzed total $860.4 million in obligations, with a 2:1 civilian-to-defense split dominated by a single $639.6 million Department of Education loan authority modification—a low-materiality, non-competitive administrative action. The highest-conviction signal is Booz Allen Hamilton's $136.2 million competitive win at Tinker AFB for IT and mission assurance support, a stable but modest revenue stream (~$24.8M/year) relative to its $10B+ revenue base. Leidos' subsidiary QTC Medical Services secured an $84.6 million VA medical exam contract, nearly fully outlayed, offering limited forward visibility. Key risk: the Education contract provides no actionable competitive or revenue insight, skewing aggregate data. Watch for Booz Allen option exercises at Tinker AFB and follow-on VA Region 1 medical exam awards for Leidos.

3 total filings
· daily

Federal IT & Cybersecurity Contracts — August 13, 2026

This digest covers a single $136.2 million contract awarded to Booz Allen Hamilton by the General Services Administration (GSA) for IT and professional support services at Tinker AFB, Oklahoma. The contract is entirely defense-adjacent, with a neutral signal strength of 5/10 and low materiality at 3/10, reflecting a competitive win under full-and-open competition with no set-asides. The time-and-materials pricing introduces moderate execution risk, while the long performance period through January 2026 provides stable but non-transformative revenue. Key watch items include option exercise pace and the resolution of negative outlays to positive cash flow.

1 total filings
· daily

Mega Contracts Monitor ($100M+) — August 13, 2026

This digest covers two contracts totaling $775.8 million, split between a $639.6 million civilian award from the Department of Education to the Missouri Higher Education Loan Authority (MOHELA) and a $136.2 million defense-adjacent IT services award from the GSA to Booz Allen Hamilton for Tinker AFB. The dominant theme is the contrast between a large, opaque civilian loan servicing modification and a competitive, time-and-materials defense IT win. The highest-conviction signal is Booz Allen's competitive win, which provides stable, multi-year revenue but carries execution risk due to its time-and-materials pricing structure. A key risk is the lack of detail on the MOHELA award, which limits assessment of its competitive dynamics and budget durability.

2 total filings